2008
Childhood Disorders: The Pervasive Developmental Disorders
McPartland J, Klin A, Westphal A, Volkmar F. Childhood Disorders: The Pervasive Developmental Disorders. 2008, 779-803. DOI: 10.1002/9780470515167.ch45.ChaptersChildhood disintegrative disorderPervasive developmental disorderDevelopmental disordersAppropriate diagnostic assessmentRett disorderEtiologic featuresPsychiatric treatmentDiagnostic assessmentDisordersAtypical patternsAutistic disorderDisintegrative disorderDistinct phenotypicAutism spectrum disorderMultiple areasCurrent knowledgeSpectrum disorderAsperger's disorderDysfunction
2000
Asperger's disorder and higher functioning autism: Same or different?
Volkmar F, Klin A. Asperger's disorder and higher functioning autism: Same or different? International Review Of Research In Mental Retardation 2000, 23: 83-110. DOI: 10.1016/s0074-7750(00)80007-5.Peer-Reviewed Original ResearchAsperger syndromeAsperger's disorderChronic developmental disorderHigh functioning autismFunctioning autismVerbal skillsResponse treatmentLanguage skillsSocial dysfunctionStudy of validityHigh functioningAutismIntervention programsDevelopmental disordersSkillsDisordersSchizophreniaValidityImportant strengthsFunctioningLearningChildrenEarly impetusFirst placePervasiveness
1999
Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use
MARTIN A, SCAHILL L, KLIN A, VOLKMAR F. Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 923-931. PMID: 10405512, DOI: 10.1097/00004583-199907000-00024.Peer-Reviewed Original ResearchConceptsPsychotropic drug useHigher-functioning pervasive developmental disordersPervasive developmental disorderTarget symptomsDrug useMedication use patternsPsychotropic medication useDevelopmental disordersMedication history informationMore medicationsMedication useClinical presentationPsychiatric comorbidityClinical variablesPsychotropic agentsDrug classesClinical heterogeneityDisordersSymptomsSubjectsAsperger's disorderFull Scale IQComorbiditiesMedicationsAntidepressants
1997
Risperidone Treatment of Children and Adolescents With Pervasive Developmental Disorders: A Prospective, Open-Label Study
MCDOUGLE C, HOLMES J, BRONSON M, ANDERSON G, VOLKMAR F, PRICE L, COHEN D. Risperidone Treatment of Children and Adolescents With Pervasive Developmental Disorders: A Prospective, Open-Label Study. Journal Of The American Academy Of Child & Adolescent Psychiatry 1997, 36: 685-693. PMID: 9136504, DOI: 10.1097/00004583-199705000-00020.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderDevelopmental disordersRisperidone treatmentClinical Global Impression ScaleOpen-label studyOpen-label trialPlacebo-controlled studyCommon side effectsEfficacy of risperidoneShort-term safetyGlobal Impression ScaleGlobal improvement itemBehavioral ratingsChildhood disintegrative disorderSocial relatednessTreatment of childrenAsperger's disorderRepetitive behaviorsAutistic disorderBehavioral symptomsBaseline visitMean ageImpression ScaleAdolescentsOptimal dose